Efficacy and Safety of S-1 in Patients with Metastatic Breast Cancer: Retrospective Review in a Single Institution

Publisher： Karger

E-ISSN： 1423-0232|79|3-4|273-277

ISSN： 0030-2414

Source： Oncology, Vol.79, Iss.3-4, 2011-03, pp. : 273-277

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Retrospective Analysis of the Activity and Safety of Oral Etoposide in Heavily Pretreated Metastatic Breast Cancer Patients

THE BREAST JOURNAL, Vol. 21, Iss. 3, 2015-05 ,pp. : 241-245

John Wiley & Sons Inc

Access to resources Recommend Favorite

Safety of Bevacizumab in Patients with Metastatic Breast Cancer

Oncology, Vol. 80, Iss. 5-6, 2011-07 ,pp. : 314-325

Karger

Access to resources Recommend Favorite

Final Safety and Efficacy Analysis of a Phase I/II Trial with Imatinib and Vinorelbine for Patients with Metastatic Breast Cancer

Oncology, Vol. 87, Iss. 5, 2014-08 ,pp. : 300-310

Karger

Access to resources Recommend Favorite

Retrospective Analysis of the Safety of Herceptin^® Immunotherapy in Metastatic Breast Cancer

Oncology, Vol. 61, Iss. 2, 2001-10 ,pp. : 58-66

Karger

Access to resources Recommend Favorite

Provision of KEL1‐negative blood to obstetric patients: a 3‐year single‐institution retrospective review

TRANSFUSION, Vol. 55, Iss. 3, 2015-03 ,pp. : 599-604

John Wiley & Sons Inc

Access to resources Recommend Favorite